MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcomaMarielle E. Yohe, Javed Khan, Hsien-Chao Chou et al.|Science Translational Medicine|2018Cited by 155
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma ModelsKatie E. Hebron, Marielle E. Yohe, Xiaolin Wan et al.|Clinical Cancer Research|2022Cited by 21